Literature DB >> 3311350

Chromosomal analysis of bladder cancer. III. Nonrandom alterations.

W Smeets1, R Pauwels, L Laarakkers, F Debruyne, J Geraedts.   

Abstract

Chromosome analysis using G- and C-banding was performed on 13 primary transitional cell carcinomas of the bladder. The chromosome preparations were obtained by a direct method. In eight tumors with a (near) diploid modal chromosome number, the most frequently observed chromosome aberrations were: (partial) monosomy 9 in four cases, deletion of 10q in two cases, and partial trisomy 1 in two cases. In five tumors with a modal chromosome number in the triploid or tetraploid range the chromosomes #1, #3, #7, #9, #11, and #17 were numerically and or structurally abnormal in at least four cases. In three out of ten males, the Y chromosome was missing. These findings suggest that the loss of chromosome #9, and possibly also loss of 10q is a primary event in the karyotypic evolution of transitional cell carcinoma of the bladder.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311350     DOI: 10.1016/0165-4608(87)90028-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  13 in total

1.  Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines.

Authors:  H M Pomykala; S K Bohlander; P L Broeker; O I Olopade; M O Díaz
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

2.  Cloning and characterization of the porcine DBC1 gene encoding deleted in bladder cancer.

Authors:  Knud Larsen; Jamal Momeni; Leila Farajzadeh; Christian Bendixen
Journal:  Mol Biol Rep       Date:  2014-09-26       Impact factor: 2.316

Review 3.  Genetics of bladder cancer.

Authors:  K K Saran; D Gould; C J Godec; R S Verma
Journal:  J Mol Med (Berl)       Date:  1996-08       Impact factor: 4.599

Review 4.  Molecular and immunopathology studies of oncogenes and tumor-suppressor genes in bladder cancer.

Authors:  C Cordon-Cardo; J Sheinfeld
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

5.  Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.

Authors:  M A Herrmann; I D Hay; D H Bartelt; S R Ritland; R J Dahl; C S Grant; R B Jenkins
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

6.  In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors.

Authors:  A H Hopman; F C Ramaekers; A K Raap; J L Beck; P Devilee; M van der Ploeg; G P Vooijs
Journal:  Histochemistry       Date:  1988

7.  Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior.

Authors:  Shyama Majumdar; Edward M Gong; Dolores Di Vizio; Jonathan Dreyfuss; David J Degraff; Martin H Hager; Peter J Park; Joaquim Bellmunt; Robert J Matusik; Jonathan E Rosenberg; Rosalyn M Adam
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

Review 8.  Bladder cancer: the molecular progression to invasive disease.

Authors:  A R Simoneau; P A Jones
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 9.  Molecular prognostic factors in bladder cancer.

Authors:  J A Vet; F M Debruyne; J A Schalken
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

10.  Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization.

Authors:  A H Hopman; P J Poddighe; A W Smeets; O Moesker; J L Beck; G P Vooijs; F C Ramaekers
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.